Email Updates

You are here

Home

8 NOVEMBER 2019 VOLUME 20 ISSUE 43

Media Coverage

  • Who Owns HIV-Prevention Drugs? The Taxpayers, US Says

    After years of prodding by patient advocates, federal officials on Wednesday sued the drug maker Gilead Sciences, charging that it had infringed government patents on the idea of preventing HIV with a daily pill. It is very rare for the government to take on a drug maker over patents. But the medications made by Gilead are necessary to end the AIDS epidemic by 2030, which the Trump administration has set as a goal. That cannot be accomplished if the drugs are not made more affordable.

    November 8, 2019
    PrEP
    New York Times

  • HHS to Gilead: Pay Up for PrEP Patent Use

    The Trump administration, on behalf of the Department of Health and Human Services (HHS), filed a patent infringement lawsuit against pharmaceutical manufacturer Gilead Sciences, seeking damages from infringement on HHS patents related to HIV prevention medications, the agency announced on Wednesday night.

    November 7, 2019
    PrEP
    MedPage Today

  • Progress on 90-90-90 HIV Targets Shows Stark Gap Between Eastern and Western Europe

    The 90-90-90 targets for HIV diagnosis, treatment and viral suppression will be missed in much of eastern Europe due to poor access to HIV treatment, the 17th European AIDS Conference (EACS 2019) heard on its opening day in Basel, Switzerland.

    November 7, 2019
    Treatment
    aidsmap

  • PrEP Services in France Are Changing in Order to Engage More People

    A recurring theme at last month’s PrEP in Europe summit in Warsaw was that the formal approval of PrEP by regulatory agencies is not enough to make PrEP a success. Much more needs to be done in order for the people who need PrEP to actually have access to it.

    November 7, 2019
    PrEP
    aidsmap

  • Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed

    As clinicians, we hear patient after patient share the same story. They are considering, or are using, the drug emtricitabine/tenofovir disoproxil fumarate (Truvada) for pre-exposure prophylaxis (PrEP) and simultaneously seeing a barrage of advertisements for a class-action lawsuit on social media and television, with frightening warnings like "Life-Threatening Side Effects" in bold letters.

    November 7, 2019
    PrEP
    The BodyPro

  • What Is on the Horizon for HIV Prevention?

    When taken consistently pre-exposure prophylaxis (PrEP) is efficacious in preventing HIV. However, one of the challenges of PrEP is that it relies on daily adherence to a once-daily pill of tenofovir disoproxil fumarate.

    November 6, 2019
    Antibody Related Research, Microbicides, PrEP
    Contagion Live

  • Scientists Discover First New HIV Strain in Nearly Two Decades

    For the first time in 19 years, a team of scientists has detected a new strain of HIV. The strain is a part of the Group M version of HIV-1, the same family of virus subtypes to blame for the global HIV pandemic, according to Abbott Laboratories, which conducted the research along with the University of Missouri, Kansas City. The findings were published Wednesday in the Journal of Acquired Immune Deficiency Syndromes.

    November 6, 2019
    General
    CNN

  • Is Uganda Winning the HIV War?

    Elvis Basudde and Hilary Bainemigisha appraise the Government, implementers, peer educators, networks of people living with or affected by HIV, counsellors, health workers, service providers, civil society and grassroots activists on whether Uganda is winning the war.

    November 6, 2019
    General
    New Vision

  • Polish PrEP Activists Creating Services and Building Demand in a Difficult Environment

    Poland might seem an odd location to hold the recent PrEP in Europe summit, given that it may be the most Catholic country in Europe and is governed by a socially conservative party that is hostile to LGBT rights. Schools do not provide sex education, dedicated sexual health services barely exist and emergency contraception is only available with a doctor’s prescription.

    November 6, 2019
    PrEP
    aidsmap

  • Topical PrEP Gel Can Be Successful in Public Sector Clinics

    Providing topical PrEP to women attending government-run family planning clinics could be a successful way to increase access and adherence to PrEP, a trial from South Africa suggests.

    November 5, 2019
    Microbicides
    Avert

  • Some European Governments Are Paying €3 a Month for PrEP, While Others Are Paying €850

    There are enormous variations in the prices European governments are paying for PrEP medication, Teymur Noori of the European Centre for Disease Prevention and Control (ECDC) told last month’s PrEP in Europe Summit in Warsaw.

    November 5, 2019
    PrEP
    aidsmap

  • For Anal Sex, Condoms With Lube Slip or Break Less Than 1% of the Time

    The largest study to date to analyze the failure rate of condoms—defined as slippage, breakage or both—has found that they fail less than 1% of the time during anal sex. The authors of the resulting paper, published in EClinical Medicine, are calling on the Food and Drug Administration (FDA) to finally approve condoms for anal sex use, just as the agency has done for vaginal sex.

    November 5, 2019
    Male and Female Condoms
    POZ

  • Do We Have the Tools to End the HIV Epidemic?

    Despite progress in decreasing HIV mortality and transmission, there are still obstacles to ending the HIV pandemic globally and in the United States.

    November 4, 2019
    General
    Contagion Live

  • To End the HIV Epidemic, Clinicians Must Mirror Community

    If you're going to end the HIV epidemic in the United States by 2030 — as the current administration has vowed to do — the systems, the providers, and the care approaches have to be set up for the people most affected by HIV; that is, people like Daniel Driffin, MPH.

    November 4, 2019
    General
    Medscape

  • It’s Time to Protect the US and the World Against Global Pandemics

    The current administration is undermining efforts to follow the science and prepare for threats of the future at a time when a new study finds that not one country is prepared for a pandemic.

    November 4, 2019
    General
    The Hill

  • Unraveling an HIV Cluster

    The county health department was staying open late just for them, so after dinner, a dozen men shuffled out of the Lifehouse drug rehabilitation shelter where they were living and climbed into a battered white van.

    November 3, 2019
    General
    Washington Post

  • The Prognosis Is Poor for Stopping the Spread of Sexually Transmitted Diseases

    Last week the Centers for Disease Control and Prevention reported that we are facing an escalating public health crisis in the United States: all-time high rates of sexually transmitted diseases, with more than 2.4 million reported cases of syphilis, gonorrhea and chlamydia in 2018.

    November 3, 2019
    General
    The Hill

  • Self-Testing Is Tool to Fight HIV Stigma

    A UNAIDS 2019 report estimates that about 23.8 million people in Africa have been diagnosed HIV positive, while another 4.7 million people could be living with HIV with no knowledge of their status.

    November 3, 2019
    General
    Daily Monitor

  • How Human Innovation Shapes Global Health

    It’s easy to forget the momentous strides that have been made in global health in the past few decades. The number of childhood deaths has more than halved since 1990 and there has been great progress in infectious diseases such as HIV/AIDS, with the number of new infections and deaths continuing to decline globally. Guinea worm disease and polio are close to being eradicated and the number of people at risk from neglected tropical diseases has fallen from two billion to 1.6 billion in the last five years.

    November 1, 2019
    General
    Scientific American

Published Research

Announcements